Overview

A Study to Evaluate Changes in Nasal Airflow of Loratadine/Pseudoephedrine Tablet and Fluticasone Propionate Nasal Spray in Subjects Following Allergen Exposure

Status:
Completed

Trial end date:
2018-05-11

Target enrollment:

Participant gender:

Summary

The purpose of the study is to evaluate changes in nasal airflow caused by loratadine 5 mg/pseudoephedrine sulfate 120 mg (Claritin D) tablet and fluticasone propionate 50 mcg per spray nasal spray (Flonase) in subjects suffering from nasal congestion and other allergy symptoms.

Phase:

Phase 4

Details

Lead Sponsor:

Bayer

Treatments:

Ephedrine
Fluticasone
Loratadine
Pseudoephedrine
Xhance